Jason Paragas is a Venture Partner at Social Impact Capital.
Paragas is part of an accomplished team of scientists utilizing novel technology platforms and fully-integrated end-to-end capabilities from discovery to GMP manufacturing, in the effort to treat cancers with novel combinations utilizing a unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines and adjuvants.
Paragas previously served as Director of Innovation at Lawrence Livermore National Labs, where he worked with teams across the laboratory, the global technology base, and sponsors to capture concepts that may become the “next big idea.” He also served as VP of External Innovation at Valo, an early-stage technology company founded in 2019 that uses cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process.
He holds a PhD in Microbiology from the Icahn School of Medicine at Mt. Sinai.